Global Opioid Induced Constipation (OIC) Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Opioid Induced Constipation (OIC) Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Opioid Induced Constipation (OIC) Drug by Country/Region, 2017, 2022 & 2028

2.2 Opioid Induced Constipation (OIC) Drug Segment by Type

2.2.1 Lubiprostone

2.2.2 Methyl Naltrexone Bromide

2.2.3 Naldemedine

2.2.4 Alvimopan

2.2.5 Other

2.3 Opioid Induced Constipation (OIC) Drug Sales by Type

2.3.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Type (2017-2022)

2.4 Opioid Induced Constipation (OIC) Drug Segment by Distribution Channel

2.4.1 Hospital Pharmacies

2.4.2 Retail Pharmacies

2.4.3 Online Pharmacies

2.5 Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel

2.5.1 Global Opioid Induced Constipation (OIC) Drug Sale Market Share by Distribution Channel (2017-2022)

2.5.2 Global Opioid Induced Constipation (OIC) Drug Revenue and Market Share by Distribution Channel (2017-2022)

2.5.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Distribution Channel (2017-2022)

3 Global Opioid Induced Constipation (OIC) Drug by Company

3.1 Global Opioid Induced Constipation (OIC) Drug Breakdown Data by Company

3.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Company (2020-2022)

3.1.2 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2020-2022)

3.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Company (2020-2022)

3.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company (2020-2022)

3.3 Global Opioid Induced Constipation (OIC) Drug Sale Price by Company

3.4 Key Manufacturers Opioid Induced Constipation (OIC) Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Opioid Induced Constipation (OIC) Drug Product Location Distribution

3.4.2 Players Opioid Induced Constipation (OIC) Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Opioid Induced Constipation (OIC) Drug by Geographic Region

4.1 World Historic Opioid Induced Constipation (OIC) Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Geographic Region

4.2 World Historic Opioid Induced Constipation (OIC) Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Opioid Induced Constipation (OIC) Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue by Country/Region

4.3 Americas Opioid Induced Constipation (OIC) Drug Sales Growth

4.4 APAC Opioid Induced Constipation (OIC) Drug Sales Growth

4.5 Europe Opioid Induced Constipation (OIC) Drug Sales Growth

4.6 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Growth

5 Americas

5.1 Americas Opioid Induced Constipation (OIC) Drug Sales by Country

5.1.1 Americas Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022)

5.1.2 Americas Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022)

5.2 Americas Opioid Induced Constipation (OIC) Drug Sales by Type

5.3 Americas Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Opioid Induced Constipation (OIC) Drug Sales by Region

6.1.1 APAC Opioid Induced Constipation (OIC) Drug Sales by Region (2017-2022)

6.1.2 APAC Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2022)

6.2 APAC Opioid Induced Constipation (OIC) Drug Sales by Type

6.3 APAC Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Opioid Induced Constipation (OIC) Drug by Country

7.1.1 Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022)

7.1.2 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022)

7.2 Europe Opioid Induced Constipation (OIC) Drug Sales by Type

7.3 Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug by Country

8.1.1 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type

8.3 Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drug

10.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug

10.4 Industry Chain Structure of Opioid Induced Constipation (OIC) Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Opioid Induced Constipation (OIC) Drug Distributors

11.3 Opioid Induced Constipation (OIC) Drug Customer

12 World Forecast Review for Opioid Induced Constipation (OIC) Drug by Geographic Region

12.1 Global Opioid Induced Constipation (OIC) Drug Market Size Forecast by Region

12.1.1 Global Opioid Induced Constipation (OIC) Drug Forecast by Region (2023-2028)

12.1.2 Global Opioid Induced Constipation (OIC) Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Opioid Induced Constipation (OIC) Drug Forecast by Type

12.7 Global Opioid Induced Constipation (OIC) Drug Forecast by Distribution Channel

13 Key Players Analysis

13.1 Ironwood Pharmaceuticals

13.1.1 Ironwood Pharmaceuticals Company Information

13.1.2 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Offered

13.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Ironwood Pharmaceuticals Main Business Overview

13.1.5 Ironwood Pharmaceuticals Latest Developments

13.2 Daiichi Sankyo Co

13.2.1 Daiichi Sankyo Co Company Information

13.2.2 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Offered

13.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Daiichi Sankyo Co Main Business Overview

13.2.5 Daiichi Sankyo Co Latest Developments

13.3 Pfizer

13.3.1 Pfizer Company Information

13.3.2 Pfizer Opioid Induced Constipation (OIC) Drug Product Offered

13.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Pfizer Main Business Overview

13.3.5 Pfizer Latest Developments

13.4 Progenics Pharmaceuticals

13.4.1 Progenics Pharmaceuticals Company Information

13.4.2 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Offered

13.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Progenics Pharmaceuticals Main Business Overview

13.4.5 Progenics Pharmaceuticals Latest Developments

13.5 Shionogi &

13.5.1 Shionogi & Company Information

13.5.2 Shionogi & Opioid Induced Constipation (OIC) Drug Product Offered

13.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Shionogi & Main Business Overview

13.5.5 Shionogi & Latest Developments

13.6 Allergan

13.6.1 Allergan Company Information

13.6.2 Allergan Opioid Induced Constipation (OIC) Drug Product Offered

13.6.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Allergan Main Business Overview

13.6.5 Allergan Latest Developments

13.7 Nektar Therapeutics

13.7.1 Nektar Therapeutics Company Information

13.7.2 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Offered

13.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Nektar Therapeutics Main Business Overview

13.7.5 Nektar Therapeutics Latest Developments

13.8 Purdue Pharma

13.8.1 Purdue Pharma Company Information

13.8.2 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Offered

13.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Purdue Pharma Main Business Overview

13.8.5 Purdue Pharma Latest Developments

13.9 S.L.A. Pharma

13.9.1 S.L.A. Pharma Company Information

13.9.2 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Offered

13.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 S.L.A. Pharma Main Business Overview

13.9.5 S.L.A. Pharma Latest Developments

13.10 Mundipharma International Limited

13.10.1 Mundipharma International Limited Company Information

13.10.2 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Offered

13.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Mundipharma International Limited Main Business Overview

13.10.5 Mundipharma International Limited Latest Developments

13.11 Ono Pharmaceutical

13.11.1 Ono Pharmaceutical Company Information

13.11.2 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Offered

13.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Ono Pharmaceutical Main Business Overview

13.11.5 Ono Pharmaceutical Latest Developments

13.12 Takeda Pharmaceutical Company Limited

13.12.1 Takeda Pharmaceutical Company Limited Company Information

13.12.2 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Offered

13.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Takeda Pharmaceutical Company Limited Main Business Overview

13.12.5 Takeda Pharmaceutical Company Limited Latest Developments

13.13 Theravance Biopharma

13.13.1 Theravance Biopharma Company Information

13.13.2 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Offered

13.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Theravance Biopharma Main Business Overview

13.13.5 Theravance Biopharma Latest Developments

13.14 Bausch Health

13.14.1 Bausch Health Company Information

13.14.2 Bausch Health Opioid Induced Constipation (OIC) Drug Product Offered

13.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Bausch Health Main Business Overview

13.14.5 Bausch Health Latest Developments

13.15 Cosmo Pharmaceuticals SA

13.15.1 Cosmo Pharmaceuticals SA Company Information

13.15.2 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Offered

13.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Cosmo Pharmaceuticals SA Main Business Overview

13.15.5 Cosmo Pharmaceuticals SA Latest Developments

13.16 Daewoong Pharmaceutical

13.16.1 Daewoong Pharmaceutical Company Information

13.16.2 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Offered

13.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Daewoong Pharmaceutical Main Business Overview

13.16.5 Daewoong Pharmaceutical Latest Developments

13.17 C.B. Fleet Company

13.17.1 C.B. Fleet Company Company Information

13.17.2 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Offered

13.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 C.B. Fleet Company Main Business Overview

13.17.5 C.B. Fleet Company Latest Developments

13.18 Sucampo Pharmaceuticals

13.18.1 Sucampo Pharmaceuticals Company Information

13.18.2 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Offered

13.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Sucampo Pharmaceuticals Main Business Overview

13.18.5 Sucampo Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

Table 1. Opioid Induced Constipation (OIC) Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Opioid Induced Constipation (OIC) Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Lubiprostone

Table 4. Major Players of Methyl Naltrexone Bromide

Table 5. Major Players of Naldemedine

Table 6. Major Players of Alvimopan

Table 7. Major Players of Other

Table 8. Global Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)

Table 9. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2022)

Table 10. Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2017-2022) & ($ million)

Table 11. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2017-2022)

Table 12. Global Opioid Induced Constipation (OIC) Drug Sale Price by Type (2017-2022) & (USD/Unit)

Table 13. Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)

Table 14. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2022)

Table 15. Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2017-2022)

Table 16. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2017-2022)

Table 17. Global Opioid Induced Constipation (OIC) Drug Sale Price by Distribution Channel (2017-2022) & (USD/Unit)

Table 18. Global Opioid Induced Constipation (OIC) Drug Sales by Company (2020-2022) & (K Units)

Table 19. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Company (2020-2022)

Table 20. Global Opioid Induced Constipation (OIC) Drug Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company (2020-2022)

Table 22. Global Opioid Induced Constipation (OIC) Drug Sale Price by Company (2020-2022) & (USD/Unit)

Table 23. Key Manufacturers Opioid Induced Constipation (OIC) Drug Producing Area Distribution and Sales Area

Table 24. Players Opioid Induced Constipation (OIC) Drug Products Offered

Table 25. Opioid Induced Constipation (OIC) Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Opioid Induced Constipation (OIC) Drug Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Geographic Region (2017-2022)

Table 30. Global Opioid Induced Constipation (OIC) Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Opioid Induced Constipation (OIC) Drug Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Country/Region (2017-2022)

Table 34. Global Opioid Induced Constipation (OIC) Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022) & (K Units)

Table 37. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2017-2022)

Table 38. Americas Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2017-2022)

Table 40. Americas Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)

Table 41. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2022)

Table 42. Americas Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)

Table 43. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2022)

Table 44. APAC Opioid Induced Constipation (OIC) Drug Sales by Region (2017-2022) & (K Units)

Table 45. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2017-2022)

Table 46. APAC Opioid Induced Constipation (OIC) Drug Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2017-2022)

Table 48. APAC Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)

Table 49. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2022)

Table 50. APAC Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)

Table 51. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2022)

Table 52. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022) & (K Units)

Table 53. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2017-2022)

Table 54. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2017-2022)

Table 56. Europe Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)

Table 57. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2022)

Table 58. Europe Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)

Table 59. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2022)

Table 60. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2017-2022) & (K Units)

Table 67. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Opioid Induced Constipation (OIC) Drug

Table 69. Key Market Challenges & Risks of Opioid Induced Constipation (OIC) Drug

Table 70. Key Industry Trends of Opioid Induced Constipation (OIC) Drug

Table 71. Opioid Induced Constipation (OIC) Drug Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Opioid Induced Constipation (OIC) Drug Distributors List

Table 74. Opioid Induced Constipation (OIC) Drug Customer List

Table 75. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global Opioid Induced Constipation (OIC) Drug Sales Market Forecast by Region

Table 77. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Opioid Induced Constipation (OIC) Drug Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC Opioid Induced Constipation (OIC) Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Opioid Induced Constipation (OIC) Drug Sales Forecast by Distribution Channel (2023-2028) & (K Units)

Table 92. Global Opioid Induced Constipation (OIC) Drug Sales Market Share Forecast by Distribution Channel (2023-2028)

Table 93. Global Opioid Induced Constipation (OIC) Drug Revenue Forecast by Distribution Channel (2023-2028) & ($ Millions)

Table 94. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share Forecast by Distribution Channel (2023-2028)

Table 95. Ironwood Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 96. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Offered

Table 97. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 98. Ironwood Pharmaceuticals Main Business

Table 99. Ironwood Pharmaceuticals Latest Developments

Table 100. Daiichi Sankyo Co Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 101. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Offered

Table 102. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 103. Daiichi Sankyo Co Main Business

Table 104. Daiichi Sankyo Co Latest Developments

Table 105. Pfizer Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 106. Pfizer Opioid Induced Constipation (OIC) Drug Product Offered

Table 107. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 108. Pfizer Main Business

Table 109. Pfizer Latest Developments

Table 110. Progenics Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 111. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Offered

Table 112. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 113. Progenics Pharmaceuticals Main Business

Table 114. Progenics Pharmaceuticals Latest Developments

Table 115. Shionogi & Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 116. Shionogi & Opioid Induced Constipation (OIC) Drug Product Offered

Table 117. Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 118. Shionogi & Main Business

Table 119. Shionogi & Latest Developments

Table 120. Allergan Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 121. Allergan Opioid Induced Constipation (OIC) Drug Product Offered

Table 122. Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 123. Allergan Main Business

Table 124. Allergan Latest Developments

Table 125. Nektar Therapeutics Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 126. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Offered

Table 127. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 128. Nektar Therapeutics Main Business

Table 129. Nektar Therapeutics Latest Developments

Table 130. Purdue Pharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 131. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Offered

Table 132. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 133. Purdue Pharma Main Business

Table 134. Purdue Pharma Latest Developments

Table 135. S.L.A. Pharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 136. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Offered

Table 137. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 138. S.L.A. Pharma Main Business

Table 139. S.L.A. Pharma Latest Developments

Table 140. Mundipharma International Limited Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 141. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Offered

Table 142. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 143. Mundipharma International Limited Main Business

Table 144. Mundipharma International Limited Latest Developments

Table 145. Ono Pharmaceutical Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 146. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Offered

Table 147. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 148. Ono Pharmaceutical Main Business

Table 149. Ono Pharmaceutical Latest Developments

Table 150. Takeda Pharmaceutical Company Limited Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 151. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Offered

Table 152. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 153. Takeda Pharmaceutical Company Limited Main Business

Table 154. Takeda Pharmaceutical Company Limited Latest Developments

Table 155. Theravance Biopharma Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 156. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Offered

Table 157. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 158. Theravance Biopharma Main Business

Table 159. Theravance Biopharma Latest Developments

Table 160. Bausch Health Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 161. Bausch Health Opioid Induced Constipation (OIC) Drug Product Offered

Table 162. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 163. Bausch Health Main Business

Table 164. Bausch Health Latest Developments

Table 165. Cosmo Pharmaceuticals SA Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 166. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Offered

Table 167. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 168. Cosmo Pharmaceuticals SA Main Business

Table 169. Cosmo Pharmaceuticals SA Latest Developments

Table 170. Daewoong Pharmaceutical Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 171. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Offered

Table 172. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 173. Daewoong Pharmaceutical Main Business

Table 174. Daewoong Pharmaceutical Latest Developments

Table 175. C.B. Fleet Company Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 176. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Offered

Table 177. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 178. C.B. Fleet Company Main Business

Table 179. C.B. Fleet Company Latest Developments

Table 180. Sucampo Pharmaceuticals Basic Information, Opioid Induced Constipation (OIC) Drug Manufacturing Base, Sales Area and Its Competitors

Table 181. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Offered

Table 182. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 183. Sucampo Pharmaceuticals Main Business

Table 184. Sucampo Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Opioid Induced Constipation (OIC) Drug

Figure 2. Opioid Induced Constipation (OIC) Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Opioid Induced Constipation (OIC) Drug Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Opioid Induced Constipation (OIC) Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Opioid Induced Constipation (OIC) Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Lubiprostone

Figure 10. Product Picture of Methyl Naltrexone Bromide

Figure 11. Product Picture of Naldemedine

Figure 12. Product Picture of Alvimopan

Figure 13. Product Picture of Other

Figure 14. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type in 2021

Figure 15. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2017-2022)

Figure 16. Opioid Induced Constipation (OIC) Drug Consumed in Hospital Pharmacies

Figure 17. Global Opioid Induced Constipation (OIC) Drug Market: Hospital Pharmacies (2017-2022) & (K Units)

Figure 18. Opioid Induced Constipation (OIC) Drug Consumed in Retail Pharmacies

Figure 19. Global Opioid Induced Constipation (OIC) Drug Market: Retail Pharmacies (2017-2022) & (K Units)

Figure 20. Opioid Induced Constipation (OIC) Drug Consumed in Online Pharmacies

Figure 21. Global Opioid Induced Constipation (OIC) Drug Market: Online Pharmacies (2017-2022) & (K Units)

Figure 22. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2017-2022)

Figure 23. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel in 2021

Figure 24. Opioid Induced Constipation (OIC) Drug Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Company in 2021

Figure 26. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Geographic Region in 2021

Figure 28. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2017-2022)

Figure 29. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country/Region in 2021

Figure 30. Americas Opioid Induced Constipation (OIC) Drug Sales 2017-2022 (K Units)

Figure 31. Americas Opioid Induced Constipation (OIC) Drug Revenue 2017-2022 ($ Millions)

Figure 32. APAC Opioid Induced Constipation (OIC) Drug Sales 2017-2022 (K Units)

Figure 33. APAC Opioid Induced Constipation (OIC) Drug Revenue 2017-2022 ($ Millions)

Figure 34. Europe Opioid Induced Constipation (OIC) Drug Sales 2017-2022 (K Units)

Figure 35. Europe Opioid Induced Constipation (OIC) Drug Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales 2017-2022 (K Units)

Figure 37. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue 2017-2022 ($ Millions)

Figure 38. Americas Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2021

Figure 39. Americas Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2021

Figure 40. United States Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Opioid Induced Constipation (OIC) Drug Sales Market Share by Region in 2021

Figure 45. APAC Opioid Induced Constipation (OIC) Drug Revenue Market Share by Regions in 2021

Figure 46. China Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2021

Figure 53. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2021

Figure 54. Germany Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country in 2021

Figure 61. Egypt Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Opioid Induced Constipation (OIC) Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Opioid Induced Constipation (OIC) Drug in 2021

Figure 67. Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drug

Figure 68. Industry Chain Structure of Opioid Induced Constipation (OIC) Drug

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles